fluorodopa f 18 has been researched along with Malignant Melanoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aouidad, I; Jublanc, C; Montravers, F; Talbot, JN; Zhang-Yin, J | 1 |
| Balan, K; Seshadri, N; Wat, J | 1 |
| Burger, C; Dimitrakopoulou-Strauss, A; Strauss, LG | 1 |
| Graham, MM | 1 |
4 other study(ies) available for fluorodopa f 18 and Malignant Melanoma
| Article | Year |
|---|---|
Incidental Metastatic Melanoma Identified on 18F-FDOPA PET/CT With Confirmation by Histology.
Topics: Dihydroxyphenylalanine; Female; Humans; Incidental Findings; Melanoma; Middle Aged; Neoplasm Staging; Paraganglioma; Positron Emission Tomography Computed Tomography; Recurrence | 2020 |
Bilateral adrenal metastases from malignant melanoma: concordant findings on (18)F-FDG and (18)F-FDOPA PET.
Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Male; Melanoma; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Skin Neoplasms | 2006 |
Quantitative PET studies in pretreated melanoma patients: a comparison of 6-[18F]fluoro-L-dopa with 18F-FDG and (15)O-water using compartment and noncompartment analysis.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Models, Theoretical; Oxygen Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2001 |
Combined 18F-FDG-FDOPA tumor imaging for assessing response to therapy.
Topics: Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Humans; Melanoma; Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2001 |